Free shipping on all orders over $ 500


Cat. No. M21067
LY3154885 Structure
Size Price Availability
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

LY3154885 is an orally active dopamine D1 receptor orthosteric modulator (PAM).

Chemical Information
Molecular Weight 444.35
Formula C23H23Cl2N3O2
CAS Number 2379422-72-5
Solubility (25°C) N/A
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.


[1] Junliang Hao, et al. J Med Chem. Synthesis and Preclinical Characterization of LY3154885, a Human Dopamine D1 Receptor Positive Allosteric Modulator with an Improved Nonclinical Drug-Drug Interaction Risk Profile

Related Dopamine Receptor Products

D-Tetrahydropalmatine is an isoquinoline alkaloid, mainly in the genus Corydalis.

Ensaculin free base

Ensaculin free base (KA-672) is a NMDA antagonist and have high affinities to serotonergic 5-HT1A and 5-HT7 receptors, adrenergic α1, and dopaminergic D2 and D3 receptors.


NPEC-caged-dopamine is a caged version of dopamine.

D4R agonist-1

D4R agonist-1 is a D4R partial agonist (Ki: 2.2 nM).

SKF 83822

SKF 83822 is an atypical agonist of dopamine D1 receptor.

Abmole Inhibitor Catalog

Keywords: LY3154885 supplier, Dopamine Receptor, inhibitors, activators

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.